Published in Mar Drugs on May 02, 2016
Marine biotechnology: diving deeper for drugs. Microb Biotechnol (2016) 0.75
Emerging Sponge Models of Animal-Microbe Symbioses. Front Microbiol (2016) 0.75
Recovery of Previously Uncultured Bacterial Genera from Three Mediterranean Sponges. Mar Biotechnol (NY) (2017) 0.75
Symbiosis-inspired approaches to antibiotic discovery. Nat Prod Rep (2017) 0.75
Furanoterpene Diversity and Variability in the Marine Sponge Spongia officinalis, from Untargeted LC-MS/MS Metabolomic Profiling to Furanolactam Derivatives. Metabolites (2017) 0.75
antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res (2011) 9.22
Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis (2005) 9.06
Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev (2010) 7.35
A new antibiotic kills pathogens without detectable resistance. Nature (2015) 6.33
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev (1999) 5.84
Fungal secondary metabolism - from biochemistry to genomics. Nat Rev Microbiol (2005) 5.27
Sponge-associated microorganisms: evolution, ecology, and biotechnological potential. Microbiol Mol Biol Rev (2007) 5.24
Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev (2009) 3.57
Targeted access to the genomes of low-abundance organisms in complex microbial communities. Appl Environ Microbiol (2007) 3.55
Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev (1998) 3.48
A polyketide synthase-peptide synthetase gene cluster from an uncultured bacterial symbiont of Paederus beetles. Proc Natl Acad Sci U S A (2002) 3.44
Why is big Pharma getting out of antibacterial drug discovery? Curr Opin Microbiol (2003) 3.30
Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei. Proc Natl Acad Sci U S A (2004) 3.01
Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother (2005) 2.62
Marine sponges as pharmacy. Mar Biotechnol (NY) (2005) 2.49
Novel approaches to developing new antibiotics for bacterial infections. Br J Pharmacol (2007) 2.43
Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem Rev (2004) 2.37
An environmental bacterial taxon with a large and distinct metabolic repertoire. Nature (2014) 2.31
In vivo antimalarial activity of the beta-carboline alkaloid manzamine A. Antimicrob Agents Chemother (2000) 2.23
Metagenomic analyses: past and future trends. Appl Environ Microbiol (2010) 2.21
Marine drugs from sponge-microbe association--a review. Mar Drugs (2010) 2.11
Halogenation strategies in natural product biosynthesis. Chem Biol (2008) 2.08
Isolation of antibiotics turbomycin a and B from a metagenomic library of soil microbial DNA. Appl Environ Microbiol (2002) 1.89
Genomic insights into the marine sponge microbiome. Nat Rev Microbiol (2012) 1.83
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge. J Nat Prod (2003) 1.81
Metagenomic analysis reveals diverse polyketide synthase gene clusters in microorganisms associated with the marine sponge Discodermia dissoluta. Appl Environ Microbiol (2005) 1.78
Polyketide assembly lines of uncultivated sponge symbionts from structure-based gene targeting. Nat Chem Biol (2009) 1.75
Expression and isolation of antimicrobial small molecules from soil DNA libraries. J Mol Microbiol Biotechnol (2001) 1.60
Marine sponges: potential sources of new antimicrobial drugs. Curr Pharm Biotechnol (2009) 1.60
Isolation and phylogenetic analysis of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. FEMS Microbiol Ecol (2001) 1.58
PacBio Sequencing and Its Applications. Genomics Proteomics Bioinformatics (2015) 1.57
A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol (2010) 1.56
Novel natural products from soil DNA libraries in a streptomycete host. Org Lett (2000) 1.52
Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol (2009) 1.44
Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA. Org Lett (2001) 1.43
Antiviral lead compounds from marine sponges. Mar Drugs (2010) 1.40
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. J Nat Prod (2004) 1.36
Streptomyces as symbionts: an emerging and widespread theme? FEMS Microbiol Rev (2011) 1.35
Antifungal drug discovery: something old and something new. PLoS Pathog (2012) 1.34
Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar Biotechnol (NY) (2008) 1.30
Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J Ind Microbiol Biotechnol (2010) 1.28
Exploring the chemistry of uncultivated bacterial symbionts: antitumor polyketides of the pederin family. J Nat Prod (2005) 1.28
Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MAD08. Appl Microbiol Biotechnol (2009) 1.28
Unprecedented diversity of catalytic domains in the first four modules of the putative pederin polyketide synthase. Chembiochem (2004) 1.27
Metabolites from an Antarctic sponge-associated bacterium, Pseudomonas aeruginosa. J Nat Prod (1996) 1.27
Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat Biotechnol (2006) 1.25
Marine actinomycetes related to the "Salinospora" group from the Great Barrier Reef sponge Pseudoceratina clavata. Environ Microbiol (2005) 1.25
Antibacterials from the sea. Chemistry (2010) 1.25
Marine antimalarials. Mar Drugs (2009) 1.23
Targeting modular polyketide synthases with iteratively acting acyltransferases from metagenomes of uncultured bacterial consortia. Environ Microbiol (2004) 1.23
Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges. Mar Drugs (2010) 1.22
Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat Prod Rep (2013) 1.16
Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes. Mar Drugs (2010) 1.15
Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery. Biotechnol Adv (2014) 1.14
Marine compounds and their antiviral activities. Antiviral Res (2010) 1.13
Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. Curr Opin Microbiol (2010) 1.12
Targeting non-multiplying organisms as a way to develop novel antimicrobials. Trends Pharmacol Sci (2008) 1.11
Approaches to capturing and designing biologically active small molecules produced by uncultured microbes. Annu Rev Microbiol (2011) 1.07
Comprehensive investigation of marine Actinobacteria associated with the sponge Halichondria panicea. Appl Environ Microbiol (2010) 1.07
Kocurin, the true structure of PM181104, an anti-methicillin-resistant Staphylococcus aureus (MRSA) thiazolyl peptide from the marine-derived bacterium Kocuria palustris. Mar Drugs (2013) 1.06
Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India. Microbiol Res (2005) 1.06
Three new metabolites from marine-derived fungi of the genera coniothyrium and microsphaeropsis J Nat Prod (1999) 1.03
Metagenomic approaches for exploiting uncultivated bacteria as a resource for novel biosynthetic enzymology. Chem Biol (2013) 1.03
Antibacterial potential of sponge endosymbiont marine Enterobacter sp at Kavaratti Island, Lakshadweep archipelago. Asian Pac J Trop Med (2012) 1.01
Discovering new antimicrobial agents. Int J Antimicrob Agents (2010) 1.00
Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria. Bioorg Med Chem Lett (2010) 0.99
Co-cultivation--a powerful emerging tool for enhancing the chemical diversity of microorganisms. Mar Drugs (2014) 0.99
Natural products in soil microbe interactions and evolution. Nat Prod Rep (2015) 0.98
Emerging systemic fungal infections. Clin Dermatol (2012) 0.98
Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity. ACS Chem Biol (2012) 0.98
Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea. J Nat Prod (2010) 0.97
Metagenomic approaches to exploit the biotechnological potential of the microbial consortia of marine sponges. Appl Microbiol Biotechnol (2007) 0.97
Novel antimycin antibiotics, urauchimycins A and B, produced by marine actinomycete. J Antibiot (Tokyo) (1993) 0.96
Phosphorus sequestration in the form of polyphosphate by microbial symbionts in marine sponges. Proc Natl Acad Sci U S A (2015) 0.96
Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar Drugs (2012) 0.95
Multiple approaches to enhance the cultivability of bacteria associated with the marine sponge Haliclona (gellius) sp. Appl Environ Microbiol (2011) 0.94
Marine natural products. XXXIV. Trisindoline, a new antibiotic indole trimer, produced by a bacterium of Vibrio sp. separated from the marine sponge Hyrtios altum. Chem Pharm Bull (Tokyo) (1994) 0.94
Halogenated indole alkaloids from marine invertebrates. Mar Drugs (2010) 0.94
Bioprospecting for antituberculosis leads from microbial metabolites. Nat Prod Rep (2010) 0.93
Screening for novel enzymes from metagenome and SIGEX, as a way to improve it. Microb Cell Fact (2005) 0.93
Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73. J Nat Prod (2013) 0.93
The sponge-associated bacterium Bacillus licheniformis SAB1: a source of antimicrobial compounds. Mar Drugs (2010) 0.93
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research. Clin Microbiol Rev (2014) 0.92
Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges. J Appl Microbiol (2011) 0.91
Antibacterial bisabolane-type sesquiterpenoids from the sponge-derived fungus Aspergillus sp. Mar Drugs (2012) 0.91
Diversity and antimicrobial activities of microbes from two Irish marine sponges, Suberites carnosus and Leucosolenia sp. J Appl Microbiol (2011) 0.90
Lectin, a possible basis for symbiosis between bacteria and sponges. J Bacteriol (1981) 0.90
Antimicrobial activities and matrix-assisted laser desorption/ionization mass spectrometry of Bacillus isolates from the marine sponge Aplysina aerophoba. Mar Biotechnol (NY) (2004) 0.90
Accumulation of the antibiotic phenazine-1-carboxylic acid in the rhizosphere of dryland cereals. Appl Environ Microbiol (2011) 0.90
Novel antibacterial proteins from the microbial communities associated with the sponge Cymbastela concentrica and the green alga Ulva australis. Appl Environ Microbiol (2010) 0.90
YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge II. Structure elucidation. J Antibiot (Tokyo) (2003) 0.89
Cultivation of sponges, sponge cells and symbionts: achievements and future prospects. Adv Mar Biol (2012) 0.89
Dereplication strategies for targeted isolation of new antitrypanosomal actinosporins A and B from a marine sponge associated-Actinokineospora sp. EG49. Mar Drugs (2014) 0.88
Pyronepolyene C-glucosides with NF-κB inhibitory and anti-influenza A viral (H1N1) activities from the sponge-associated fungus Epicoccum sp. JJY40. Bioorg Med Chem Lett (2012) 0.88
Antibacterial potential of antagonistic Streptomyces sp. isolated from marine sponge Dendrilla nigra. FEMS Microbiol Ecol (2004) 0.88
Isolation, characterization and phylogeny of sponge-associated bacteria with antimicrobial activities from Brazil. Res Microbiol (2010) 0.88
Biotechnological potential of sponge-associated bacteria. Curr Pharm Biotechnol (2014) 0.87
Sponge-derived Kocuria and Micrococcus spp. as sources of the new thiazolyl peptide antibiotic kocurin. Mar Drugs (2013) 0.87
Mining the metabiome: identifying novel natural products from microbial communities. Chem Biol (2014) 0.86